Literature DB >> 1679864

Chronic fatigue syndrome: clinical condition associated with immune activation.

A L Landay1, C Jessop, E T Lennette, J A Levy.   

Abstract

There is much conflicting immunological and viral data about the causes of chronic fatigue syndrome (CFS); some findings support the notion that CFS may be due to one or more immune disorders that have resulted from exposure to an infectious agent. In the present study, flow cytometry and several different monoclonal antibodies recognising T, B, and natural killer (NK) cell populations as well as activation and cell adhesion antigens were used to study 147 individuals with CFS. Compared with healthy controls, a reduced CD8 suppressor cell population and increased activation markers (CD38, HLA-DR) on CD8 cells were found. The differences were significant (p = 0.01) in patient with major symptoms of the disease. These immunological indices were not observed in 80 healthy individuals, in 22 contacts of CFS patients, or in 43 patients with other diseases. No correlation of these findings in CFS patients with any known human viruses could be detected by serology. The findings suggest that immune activation is associated with many cases of CFS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679864     DOI: 10.1016/0140-6736(91)91440-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  55 in total

1.  Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion.

Authors:  J J LaManca; S A Sisto; X D Zhou; J E Ottenweller; S Cook; A Peckerman; Q Zhang; T N Denny; W C Gause; B H Natelson
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

Review 2.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Reproducibility of immunological tests used to assess multiple chemical sensitivity syndrome.

Authors:  Donald R Hoover; Albert Donnay; Clifford S Mitchell; Grace Ziem; Noel R Rose; Daniel E Sabath; Edward J Yurkow; Robert Nakamura; Robert F Vogt; Myron Waxdal; Joseph B Margolick
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

Review 4.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 5.  The chronic fatigue syndrome.

Authors:  D G James; M G Brook; B A Bannister
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

Review 6.  Infectious diseases and AIDS.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

7.  Alleged link between hepatitis B vaccine and chronic fatigue syndrome.

Authors: 
Journal:  CMAJ       Date:  1992-01-01       Impact factor: 8.262

Review 8.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

9.  Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients.

Authors:  A Skowera; E Stewart; E T Davis; A J Cleare; C Unwin; L Hull; K Ismail; G Hossain; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

10.  Chronic fatigue syndrome: have flawed assumptions been derived from treatment-based studies?

Authors:  J A Richman; J A Flaherty; K M Rospenda
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.